LQDA vs ZBIO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LQDA Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Liquidia Corporation Common Stock (LQDA) driven by superior Valuation, Growth & Margin, Momentum & Technical while ZBIO counters with relative strength in Options & Structure. Fundamentally, LQDA trades at 16.4x Forward P/E with 47.1% operating margin (+314.6% YoY revenue) versus ZBIO at N/M Forward P/E and -2747.5% operating margin (-100.0% YoY). In options structure, LQDA sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against ZBIO sits in CONSOLIDATION (13th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | LQDA Revenue | ZBIO Revenue | LQDA Op. Margin | ZBIO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | N/A | -580.1% | N/A | LQDA |
| FY2020 | $0M | N/A | -7989.0% | N/A | LQDA |
| FY2021 | $10M | N/A | -263.0% | N/A | LQDA |
| FY2022 | $20M | N/A | -243.3% | N/A | LQDA |
| FY2023 | $20M | $50M | -419.6% | -74.3% | ZBIO |
| FY2024 | $10M | $10M | -866.6% | -3277.8% | LQDA |
| FY2025 | $160M | $10M | -32.5% | -3830.6% | LQDA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | LQDA | ZBIO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.2B | $1.9B | Larger Scale | LQDA |
| Trailing P/E Ratio Valuation | 13.8x | N/M | Lower Multiple | LQDA |
| Forward P/E Ratio Valuation | 16.4x | N/M | Lower Multiple | LQDA |
| Revenue Growth (YoY) Growth | +314.6% | -100.0% | Higher Growth | LQDA |
| Operating Margin (TTM) Profitability | 47.1% | -2747.5% | Higher Margin | LQDA |
| Net Profit Margin Profitability | -15.2% | 0.0% | Higher Margin | ZBIO |
| Return on Equity (ROE) Capital Efficiency | 131.8% | -265.1% | Higher ROE | LQDA |
| 52-Week Range Position Momentum | 48% ($22โ$94) | 46% ($14โ$45) | Stronger Trend | LQDA |
| Beta / 30D Volatility Risk Regime | 0.99ฮฒ ยท 77% Vol | 1.16ฮฒ ยท 59% Vol | Lower Realized Risk | ZBIO |
| Unified Institutional Score Composite Signal | 25.6 / 100 (SELL) | 49.4 / 100 (HOLD) | Higher Composite | ZBIO |